Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
asset sales
Biotech
Ignota buys Kronos' pipeline to rescue shelved programs
Ignota has bagged more drugs for its rehabilitation scheme, snapping up Kronos' pipeline months after setbacks drove the biotech off public markets.
Nick Paul Taylor
Oct 6, 2025 5:45am
Serina sheds AgeX assets to become debt-free
Jan 16, 2025 4:00am
Ginkgo loads up Modulus CAR assets, latest in a string of deals
Apr 2, 2024 7:01am
Organoids branded future of brain R&D as AxoSim gets Vyant tech
Oct 24, 2023 7:00am
As Federation Bio folds, Kanvas Bio picks up the pieces
Oct 11, 2023 7:00am
